“…Glycogen synthase kinase-3 (GSK3) is a serine/threonine kinase that plays a role in a diversity of intracellular signaling pathways and biological activities in development and throughout adulthood. Dysregulation of GSK3 is implicated in many major diseases, including cancer, inflammation, diabetes, cardiac hypertrophy and an array of CNS disorders (see reviews by Beurel et al, 2015;Ahmad and Woodgett, 2020;Hajka et al, 2021). In terms of brain disorders, GSK3 has been strongly implicated in, for example, sleep disorder, psychiatric illness, neurodevelopmental disorders including autism, intellectual disability, epilepsy and neurodegenerative disorders, in particular Alzheimer's disease (see reviews by Jaworski et al, 2019;Jaworski, 2020;Silva-García et al, 2020;Rizk et al, 2021;Sayas and Ávila, 2021).…”